Another excellent example of visionary delivery device strategy by Chiesi. Chiesi Was the first company to launch a triple therapy pMDI for the treatment of COPD, with Trimbow. Now they received the authorisation for their innovative product in their state of the art DPI, NextHaler. The NextHaler has been design from ground up to be patient-friendly, easy to manufacture and fill, And to be used with different formulations. This step will both increase patience choice, and at the same time will introduce additional robust IP protection to their product.

#chiesi #copd #inhaler

See more on my Linkedin: https://www.linkedin.com/posts/pietrocrovetto_chiesi-group-receives-european-marketing-activity-6791250131590156288-Xpqe